Compare BDL & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDL | OM |
|---|---|---|
| Founded | 1959 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 85.0M |
| IPO Year | N/A | 2020 |
| Metric | BDL | OM |
|---|---|---|
| Price | $28.61 | $4.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 623.0 | ★ 618.0K |
| Earning Date | 12-26-2025 | 11-10-2025 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | ★ 41.91 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $201,851,000.00 | $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | $12.90 | ★ N/A |
| Revenue Growth | ★ 8.84 | 4.65 |
| 52 Week Low | $22.61 | $4.00 |
| 52 Week High | $35.98 | $25.35 |
| Indicator | BDL | OM |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 25.54 |
| Support Level | $27.55 | $4.07 |
| Resistance Level | $30.01 | $4.63 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | -0.24 | 0.32 |
| Stochastic Oscillator | 20.27 | 18.56 |
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.